These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2905653

  • 1. Legal aspects of tardive dyskinesia.
    Davis JM, Comaty J.
    Encephale; 1988 Sep; 14 Spec No():257-61. PubMed ID: 2905653
    [Abstract] [Full Text] [Related]

  • 2. Tardive dyskinesia and informed consent: myths and realities.
    Munetz MR, Roth LH, Cornes CL.
    Bull Am Acad Psychiatry Law; 1982 Sep; 10(2):77-88. PubMed ID: 6129012
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Legal liability with psychotropic drug use: extrapyramidal syndromes and tardive dyskinesia.
    Mills MJ, Eth S.
    J Clin Psychiatry; 1987 Sep; 48 Suppl():28-33. PubMed ID: 3624218
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Update on legal issues associated with tardive dyskinesia.
    Slovenko R.
    J Clin Psychiatry; 2000 Sep; 61 Suppl 4():45-57. PubMed ID: 10739331
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Screening for tardive dyskinesia.
    Munetz MR, Schulz SC.
    J Clin Psychiatry; 1986 Feb; 47(2):75-7. PubMed ID: 2867994
    [Abstract] [Full Text] [Related]

  • 9. Micro-effects of language on risk perception in drug prescribing behavior.
    Bursztajn HJ, Chanowitz B, Gutheil TG, Hamm RM.
    Bull Am Acad Psychiatry Law; 1992 Feb; 20(1):59-66. PubMed ID: 1349499
    [Abstract] [Full Text] [Related]

  • 10. Tardive dyskinesia, impaired recall, and informed consent.
    Ganguli R, Raghu U.
    J Clin Psychiatry; 1985 Oct; 46(10):434-5. PubMed ID: 2864333
    [Abstract] [Full Text] [Related]

  • 11. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A, Lajeunesse C.
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [Abstract] [Full Text] [Related]

  • 12. Tardive-dyskinesia and lithium-associated neuropathy.
    Rogers GA.
    J Clin Psychiatry; 1981 Sep; 42(9):363-4. PubMed ID: 6115854
    [No Abstract] [Full Text] [Related]

  • 13. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
    Cancro R, Davis JM, Klawans H, Tancredi L.
    J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
    [Abstract] [Full Text] [Related]

  • 14. Tardive dyskinesia: legal and preventive aspects.
    Shriqui CL, Bradwejn J, Jones BD.
    Can J Psychiatry; 1990 Oct; 35(7):576-80. PubMed ID: 1980092
    [Abstract] [Full Text] [Related]

  • 15. Ethical issues in drug selection for schizophrenia.
    Jeffries JJ.
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S70-4. PubMed ID: 7504571
    [Abstract] [Full Text] [Related]

  • 16. Responsibility and compensation for tardive dyskinesia.
    Appelbaum PS, Schaffner K, Meisel A.
    Am J Psychiatry; 1985 Jul; 142(7):806-10. PubMed ID: 2861753
    [Abstract] [Full Text] [Related]

  • 17. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
    Lam RW, Jeste SD, Jeste DV.
    Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Minimization and overreaction to tardive dyskinesia.
    Munetz MR, Schulz SC.
    Schizophr Bull; 1986 Sep; 12(2):168-72. PubMed ID: 2872721
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.